Ancillary materials (AMs), also called raw materials in Europe, are components, reagents, and materials used in the manufacturing of cell, gene, and tissue-engineered (CGT) therapies but are not intended to be present in the final product formulation.

In this webinar, Dr. Kristin G. Anderson, Research Associate from the Greenberg lab at the Fred Hutchinson Cancer Research Center, discusses engineering T cells to improve survival in the immunosuppressive tumor microenvironment.

Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.

In drug development, microphysiological systems (MPS) are utilized to develop in vitro biological models that can generate more physiologically- and human-relevant data.

This online symposium will highlight the latest advances in proteomics and metabolomics research and their applications in modern medicine.

Attend this webinar to learn how Dr. Filip Van Petege's lab is solving crystal structures of isolated RyR domains in wild type and disease mutant forms, exploring excessive phosphorylation of RyRs as well as investigating the mechanical coupling between CaV1.1 and RyR1 in skeletal muscle.